Quality analysis of transfusion testing during plasma transfusion in patients with liver disease
肝病患者血浆输注时输血检验质量分析

摘要

目的 探讨肝病患者血浆输注过程中严格控制血浆输注对治疗效果及输血不良反应的影响。方法 选取我院2023年2月至2024年2月期间收治的100例接受血浆输注的肝病患者为研究对象，随机将其分为参照组和实验组，每组50例，参照组采取常规血浆输注，实验组则在输血前、中、后期严格控制血浆输注。对比两组输血后的血常规、肝功能指标数据以及输血过程中和输血后的不良反应发生情况。结果 输血后，实验组的血红蛋白水平显著优于参照组（P<0.05）；在肝功能指标方面，实验组ALT、AST、TBIL的下降幅度均优于参照组（P<0.05）；在输血不良反应方面，实验组总发生率显著低于参照组（P<0.05）。结论 在肝病患者血浆输注过程中，严格控制血浆输注能够显著提高输血检验质量，降低输血不良反应，促进患者肝功能恢复，是保障输血安全和有效的关键。

Abstract

Objective: To explore the effect of strict control of plasma transfusion during the process of liver disease patients on treatment efficacy and transfusion adverse reactions. Method: 100 liver disease patients who received plasma transfusion in our hospital from February 2023 to February 2024 were selected as the research subjects. They were randomly divided into a control group and an experimental group, with 50 patients in each group. The control group received routine plasma transfusion, while the experimental group strictly controlled plasma transfusion before, during, and after transfusion. Compare the blood routine, liver function indicators, and incidence of adverse reactions during and after blood transfusion between two groups. Result: After blood transfusion, the hemoglobin level in the experimental group was significantly better than that in the reference group (P<0.05); In terms of liver function indicators, the decrease in ALT, AST, and TBIL in the experimental group was better than that in the reference group (P<0.05); In terms of adverse reactions to blood transfusion, the total incidence rate in the experimental group was significantly lower than that in the reference group (P<0.05).
Conclusion  : Strict control of plasma transfusion in patients with liver disease can significantly improve the quality of transfusion testing, reduce transfusion adverse reactions, promote the recovery of liver function, and is the key to ensuring safe and effective transfusion.